Equity Overview
Price & Market Data
Price: $1.57
Daily Change: +$0.095 / 6.07%
Range: $1.43 - $1.60
Market Cap: $5,690,262
Volume: 147,639
Performance Metrics
1 Week: 29.10%
1 Month: -26.06%
3 Months: -45.31%
6 Months: -48.53%
1 Year: -94.53%
YTD: -47.50%
Company Details
Employees: 52
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United States
Details
Sunshine Biopharma, Inc. operates as a pharmaceutical company that focuses on the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. It operates through Prescription Generic Pharmaceuticals and Nonprescription Over-The-Counter Products segments. The company is developing SBFM-PL4, a protease inhibitor for the treatment of SARS coronavirus infections; Adva-27a, a small chemotherapy molecule to treat pancreatic cancer; and K1.1 mRNA, a lipid nano-particle for liver cancer. It also offers Essential 9, an amino acids capsules; Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name; and L-Citrulline and Taurine products. In addition, the company provides various generic prescription drugs for osteoporosis, cardiovascular, antipsychotic, antibacterial, hypertension, anti-inflammatory, allergy, antibiotic, central nervous system, diabetes, urology, antifungal, antimalarial, oncology, gastroenterology, and anticonvulsant indications. Sunshine The company is based in Fort Lauderdale, Florida.